These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mmp-9 immunoreactivity in acute migraine. Leira R; Sobrino T; Rodríguez-Yáñez M; Blanco M; Arias S; Castillo J Headache; 2007 May; 47(5):698-702. PubMed ID: 17501851 [TBL] [Abstract][Full Text] [Related]
3. Different circulating metalloproteinases profiles in women with migraine with and without aura. Martins-Oliveira A; Speciali JG; Dach F; Marcaccini AM; Gonçalves FM; Gerlach RF; Tanus-Santos JE Clin Chim Acta; 2009 Oct; 408(1-2):60-4. PubMed ID: 19627981 [TBL] [Abstract][Full Text] [Related]
7. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution. Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086 [TBL] [Abstract][Full Text] [Related]
8. [Proinflammatory cytokines in children with idiopathic headache]. Gergont A; Kaciński M; Kwinta P Przegl Lek; 2005; 62(11):1269-75. PubMed ID: 16512619 [TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy. Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501 [TBL] [Abstract][Full Text] [Related]
10. Specific matrix metalloproteinase 9 (MMP-9) haplotype affect the circulating MMP-9 levels in women with migraine. Martins-Oliveira A; Gonçalves FM; Speciali JG; Fontana V; Izidoro-Toledo TC; Belo VA; Dach F; Tanus-Santos JE J Neuroimmunol; 2012 Nov; 252(1-2):89-94. PubMed ID: 22907074 [TBL] [Abstract][Full Text] [Related]
11. Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Chau KY; Sivaprasad S; Patel N; Donaldson TA; Luthert PJ; Chong NV Eye (Lond); 2007 Dec; 21(12):1511-5. PubMed ID: 17304258 [TBL] [Abstract][Full Text] [Related]
12. Impact of migraine attacks on the blood-brain barrier. Gao HM; Li L; Zhang KL; Chen XH; Tian SQ; Zhang ZL Chin Med J (Engl); 2010 Sep; 123(18):2559-61. PubMed ID: 21034616 [TBL] [Abstract][Full Text] [Related]
13. Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine? Cavestro C; Rosatello A; Micca G; Ravotto M; Marino MP; Asteggiano G; Beghi E Headache; 2007; 47(10):1436-42. PubMed ID: 18052953 [TBL] [Abstract][Full Text] [Related]
14. Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Chau KY; Sivaprasad S; Patel N; Donaldson TA; Luthert PJ; Chong NV Eye (Lond); 2008 Jun; 22(6):855-9. PubMed ID: 18597988 [TBL] [Abstract][Full Text] [Related]
15. Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects. Young W; Shaw J; Bloom M; Gebeline-Myers C Headache; 2008; 48(10):1490-8. PubMed ID: 19076647 [TBL] [Abstract][Full Text] [Related]
16. Increased circulatory MMP-2 and MMP-9 levels and activities in patients with type 1 diabetes mellitus. Shiau MY; Tsai ST; Tsai KJ; Haung ML; Hsu YT; Chang YH Mt Sinai J Med; 2006 Nov; 73(7):1024-8. PubMed ID: 17195891 [TBL] [Abstract][Full Text] [Related]
17. Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome. Gómez-Hernández A; Sánchez-Galán E; Ortego M; Martín-Ventura JL; Blanco-Colio LM; Tarín-Vicente N; Jiménez-Nacher JJ; López-Bescos L; Egido J; Tuñón J Am J Cardiol; 2008 Jul; 102(1):12-8. PubMed ID: 18572029 [TBL] [Abstract][Full Text] [Related]
18. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension. Tan J; Hua Q; Xing X; Wen J; Liu R; Yang Z Hypertens Res; 2007 Oct; 30(10):959-63. PubMed ID: 18049028 [TBL] [Abstract][Full Text] [Related]
19. Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus. Chang YH; Lin IL; Tsay GJ; Yang SC; Yang TP; Ho KT; Hsu TC; Shiau MY Clin Biochem; 2008 Aug; 41(12):955-9. PubMed ID: 18471998 [TBL] [Abstract][Full Text] [Related]
20. Tissue inhibitors of matrix metalloproteinase-1 levels are increased in serum of patients with allergic contact dermatitis. Reduta T; Laudańska H; Laudanski P Contact Dermatitis; 2007 Aug; 57(2):100-4. PubMed ID: 17627649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]